# "WB-DCE-MRI" in Multiple Myeloma as an Independent Prognostic Factor for Disease-free Survival

> **NCT01171430** · NA · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 104 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DEVICE:** Whole Body Dynamic Contrast Enhanced MRI (WB-DCE-MRI)

## Key facts

- **NCT ID:** NCT01171430
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-07
- **Primary completion:** 2016-02
- **Final completion:** 2019-02
- **Target enrollment:** 104 (ACTUAL)
- **Last updated:** 2020-11-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01171430

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01171430, ""WB-DCE-MRI" in Multiple Myeloma as an Independent Prognostic Factor for Disease-free Survival". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01171430. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*